About the Company:
Earum Pharmaceuticals is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products.
Company offers around 125 pharmaceutical formulation products, of which around 24 products are marketed by the company under own brandname, the manufacturing of which is outsourced to third parties.
Apart from pharmaceutical formulation products, Company also deals in trading of active pharmaceutical ingredients (API’s) such as Levofloxacin Hemihdrate IP Albendazol IP, Amoxicillin Trihydrate IP etc.
Currently company has presence in Indian States such as Gujarat, Maharashtra, Chhattisgarh, Uttar Pradesh, Mizoram, Andhra Pradesh, Rajasthan, Madhya Pradesh,
Manipur, Assam, Meghalaya, Kerala, Telangana etc.
Pharmaceutical Formulation products such as:
anti-biotic drugs
anti-malarial drugs
anti-allergic & anti cold drugs
analgesic/ anti-pyretic & anti inflammatory drugs
dermatology products
cerebral activator drugs
neurological drugs
gastro intestinal drugs
steroids, gynecology drugs
calcium, multivitamins
anti-oxidants and injections.
Management Team:
- Mr. Bhumishth Narendrabhai Patel (Designation: Chairman & Managing Director)
- Mrs. Payal Bhumishth Patel (Designation: Whole Time Director)
Objectives of the Issue:
- To meet Working Capital requirements
- General Corporate Purpose
- To meet issue expenses
Financials of the Company:
| (in Crores) | FY 16 | FY 17 | FY 18 | 31st Dec 18 |
|---|---|---|---|---|
| Revenue | 18.63 | 23.69 | 35.84 | 34.50 |
| Net Profit | 0.097 | 0.15 | 0.85 | 0.86 |
Valuation of Peer Group Companies:
| Company Name | Face Value | EPS | PE Ratio | RoNW | NAV |
|---|---|---|---|---|---|
| Earum Pharmaceuticals Ltd | 10 | 3.50 | 10.28 | 20.34% | 136.46 |
| Vaishali Pharma Ltd | 10 | 1.41 | 30.96 | 3.87% | 25.83 |
IPO Details:
| Details | Info |
|---|---|
| Issue Opens on | 21st June 2019 |
| Issue Closes on:. | 26th June 2019 |
| Issue Price | Rs.36 |
| Face Value | Rs.10 |
| Minimum Lot | 3000 |
| Minimum Investment | Rs.1,08,000 |
| Issue Constitutes | 29.96% |
| Issue Size | Rs.6.65 cr |
| Market Cap | Rs.22.20 cr |
| Listing at | BSE SME |
| Equity Shares Offered (fresh) | 18,48,000 |
| Equity Shares Prior to the Issue | 43,19,910 |
| Equity Shares after the Issue | 61,67,910 |
IPO Valuation Parameters:
| Earnings Per Share (EPS) | Price To Earnings ratio (PE) | Return on Net Worth (RoNW) | Net Asset Value (NAV) |
|---|---|---|---|
| 3.50 | 10.28 | 20.34% | 136.46 |
| Check IPO Allotment Status: |
|---|
Bigshare Website (Click on the below Link)http://www.bigshareonline.com/bssipoapplicationstatus.aspx |
| Company Contact Info: |
|---|
| Earum Pharmaceuticals Ltd G1, Ground Floor, V R Complex, Near Sanathal Cross Road, SP Ring Road, Sanathal. Ahmedabad – 382210, Gujarat, India Tel. No.+91-79-48402525 E-mail: info@earumpharma.com Website: https://www.earumpharma.com |
| IPO Registrar Info: |
|---|
| BIGSHARE SERVICES PRIVATE LIMITED Address:-1st Floor, Bharat Tin Works Building, Opp. Vasant Oasis, Makwana Road, Marol, Andheri East, Mumbai – 400059 Tel No.:+91-022-62638200 Fax No.: +91-022-62638299 Email:ipo@bigshareonline.com Website: www.bigshareonline.com |
| Lead Manager to the Issue: |
|---|
| HEM SECURITIES LIMITED 904,A Wing, Naman Midtown, Senapati Bapat Marg, Elphinstone Road, Lower Parel, Mumbai-400013, India Tel. No.: +91- 022- 49060000 Fax No.: +91- 022- 22625991 Email: ib@hemsecurities.com Website: www.hemsecurities.com |
